MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The role and underlying mechanisms of BAG3 in regulating autophagy in PC12 cells

Y.P. Yang, Y.L. Cao, C.J. Mao, F. Wang, L.F. Hu, C.F. Liu (Suzhou, People's Republic of China)

Meeting: 2016 International Congress

Abstract Number: 1844

Keywords: Alpha-synuclein, Bcl-2 family, Neuroprotective agents, Ubiquitin proteasome system(UPS)

Session Information

Date: Thursday, June 23, 2016

Session Title: Neuropharmacology

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To detect the role of Bcl-2-associated athanogene 3 (BAG3) in regulating autophagy in PC12 cells and explore the underlying mechanisms of it.

Background: Increasing data indicate that autophagy play an important role in Parkinson’s disease (PD). But how to choose autophagic regulation target and control the degree of autophagy activation have troubled researchers for many years and need to be solved urgently. Recently, it has been reported that BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins. However, the mechanisms of it are not yet fully understood. And till now there’s no data show the role of selective autophagy mediated by BAG3 in dopaminergic neuron.

Methods: In the present study, over-expression of wild-type α-synuclein PC12 cells (WT-PC12 cells) were treatment with MG132, an inhibitor of proteasome, to developing cell model of PD. The effects of BAG3 in α-syncline’s autophagic degradation were investigated by MTT, Western blotting, Reverse transcription PCR and Immunoprecipitation. Furthermore, the regulatory mechanisms of BAG3 in autophagy were explored after overexpression or RNA interference (RNAi) of BAG3.

Results: It was found that after treatment with MG132, cell viability of WT-PC12 cells decreased in a dose dependent manner. MG132 significantly upregulated the expression of α-synuclein, but it has no effect on the gene level of it in WT-PC12 cell lines. What’s more, MG132 increased the expression BAG3, autophagy-related proteins LC3-II and P62 in WT-PC12 in a dose dependent manner. We also found that BAG3 overexpression was sufficient to enhance LC3-II level induced by MG132 in WT-PC12 cells and promote the cleareance of α-synuclein. Knockdown of BAG3 abolished the changes in LC3-II protein level induced by MG132 in WT-PC12 and result in the formation of α-synuclein. The underlying mechanisms of BAG3 in regulating autophagy rely on the HSP70-BAG3-P62 complex.

Conclusions: These results indicate that BAG3 involves in the autophagic degradation of α-synuclein in WT-PC12 cells and it has a neuroprotective effect on the injury of dopaminergic neurons induced by MG132. Increase BAG3 levels could provide a therapeutic approach to Parkinson’s disease.

To cite this abstract in AMA style:

Y.P. Yang, Y.L. Cao, C.J. Mao, F. Wang, L.F. Hu, C.F. Liu. The role and underlying mechanisms of BAG3 in regulating autophagy in PC12 cells [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/the-role-and-underlying-mechanisms-of-bag3-in-regulating-autophagy-in-pc12-cells/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-role-and-underlying-mechanisms-of-bag3-in-regulating-autophagy-in-pc12-cells/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley